FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bystolic (nebivolol hydrochloride) submitted by Allergan, Inc., resulting in labeling updates for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BYSTOLIC (nebivolol hydrochloride)

Snippet

SUPPL AP for BYSTOLIC (NEBIVOLOL HYDROCHLORIDE)